Healthcare Fund… Venture Capital in Life Sciences (III): Monoclonal Antibodies in the Treatment of Ankylosing Spondylitis 16 Apr 2014April 19, 2014 The application of monoclonal antibody drugs is a relatively new innovation. Approximately 54% of monoclonal antibody drugs available are applied in various types of cancer, although clinical trials are also…
Healthcare Fund… Venture Capital in Life Sciences (II): Pharmacogenomics and Personalized Medicine 7 Apr 2014April 7, 2014 Pharmacogenomics focuses on understanding the response rates and side effects of a treatment at the individual level. It analyzes the influence of genetic variation on drug response in patients by…